News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Napo Pharmaceuticals presents positive preliminary results for crofelemer powder in Type 1 short bowel syndrome patients at ACG 2026, focusing on reducing ostomy output and improving quality of life -
-
-